Activation of the JC Virus Tat-Responsive Transcriptional Control Element by Association of the Tat Protein of Human Immunodeficiency Virus 1 with Cellular Protein Purα

JC virus is activated to replicate in glial cells of many AIDS patients with neurological disorders. In human glial cells, the human immunodeficiency virus 1 (HIV-1) Tat protein activates the major late promoter of JC virus through a Tat-responsive DNA element, termed upTAR, which is a recognition s...

Full description

Saved in:
Bibliographic Details
Published in:Proceedings of the National Academy of Sciences - PNAS Vol. 93; no. 24; pp. 14112 - 14117
Main Authors: Krachmarov, Chavdar P., Chepenik, Lara G., Barr-Vagell, Sharon, Khalili, Kamel, Johnson, Edward M.
Format: Journal Article
Language:English
Published: United States National Academy of Sciences of the United States of America 26-11-1996
National Acad Sciences
The National Academy of Sciences
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:JC virus is activated to replicate in glial cells of many AIDS patients with neurological disorders. In human glial cells, the human immunodeficiency virus 1 (HIV-1) Tat protein activates the major late promoter of JC virus through a Tat-responsive DNA element, termed upTAR, which is a recognition site for cellular Purα , a sequence-specific single-stranded DNA binding protein implicated in cell cycle control of DNA replication and transcription. Tat interacts with two leucine-rich repeats in Purα to form a complex that can be immunoprecipitated from cell extracts. Tat enhances the ability of purified glutathione S-transferase-Purα (GST-Purα ) to bind the upTAR element. Tat acts synergistically with Purα , in a cell-cycle-dependent manner, to activate transcription at an upTAR element placed upstream of a heterologous promoter. Since Purα is ubiquitously expressed in human cells and since PUR elements are located near many promoters and origins of replication, the Tat-Purα interaction may be implicated in effects of HIV-1 throughout the full range of HIV-1-infected cells.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
To whom reprint requests should be addressed. e-mail: johnson@msvax.mssm.edu.
Thomas Shenk, Princeton University, Princeton, NJ
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.93.24.14112